cetylpyridinium chloride anhydrous and Nodular Goiter

cetylpyridinium chloride anhydrous has been researched along with Nodular Goiter in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barresi, G; Benvenga, S; Cardelli, P; Galletti, M; Ruggeri, RM; Sciacchitano, S; Trimarchi, F; Trovato, M; Vitale, A; Vitarelli, E	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Nodular Goiter

Article	Year
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals. Journal of endocrinological investigation, 2009, Volume: 32, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Goiter, Nodular; Hashimoto Disease; Health; Hepatocyte Growth Factor; Humans; Interleukin-6; Male; Middle Aged; Young Adult	2009

Article

Year

Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.

Journal of endocrinological investigation, 2009, Volume: 32, Issue:5

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Goiter, Nodular; Hashimoto Disease; Health; Hepatocyte Growth Factor; Humans; Interleukin-6; Male; Middle Aged; Young Adult

2009